INTERNATIONAL PATENT: NOVARTIS AG FILES APPLICATION FOR "TREATMENT OF MULTIPLE SCLEROSIS USING A POPULATION OF CD19 CAR-EXPRESSING CELLS"

GENEVA, May 11 -- NOVARTIS AG (Lichtstrasse 354056 Basel) filed a patent application (PCT/IB2025/060938) for "TREATMENT OF MULTIPLE SCLEROSIS USING A POPULATION OF CD19 CAR-EXPRESSING CELLS" on Oct 27, 2025. With publication no. WO/2026/093896, the details related to the patent application was published on May 07, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ADIWIJAYA, Bambang (Novartis Pharmaceuticals Corporation59 Route 10East Hanover, New Jersey 07936), AWASTHI, Rakesh (Novartis Pharmaceuticals Corporation59 Route 10East Hanover, New Jersey 07936), PEARSON, David Scott (Novartis Pharma...